Smoking Linked to Cognitive Decline in Children: Study

Aug.31.2022
Smoking Linked to Cognitive Decline in Children: Study
Smoking linked to poor cognitive performance and brain volume reduction in children, per a 2-year study on 1000+ children in Nebraska, US.

A study conducted in the state of Nebraska, United States revealed that smoking is associated with poor cognitive performance and reduced brain volume among more than 1,000 children aged 9 to 10 years old who were followed up for two years. The study found that the effects of smoking could have a lasting impact.


Among those investigated, 116 children reported using tobacco products and were considered to be the earliest group of tobacco users in the study. This group performed poorly on the tests (mean, b = -2.9; SE, 0.6; P <.001), showing lower crystallized cognitive composite scores (b = -2.4; SE, 0.5; P <.001) and total cognitive composite scores (b = -2.9; SE, 0.5; P = .01). In a follow-up study of two years, smokers had lower cortical volumes in the frontal, parietal, and temporal lobes than non-users.


According to a report by Dr. Hongying Daisy Dai, Chief Researcher at the University of Nebraska Medical Center, electronic cigarettes and smokeless tobacco products should not be considered as a substitute to traditional cigarettes for youth to reduce tobacco-related harm. Authorities should implement comprehensive intervention strategies and tobacco control policies to prevent tobacco initiation.


From October 2016 to October 2018, a study titled Adolescent Brain Cognitive Development (ABCD) included 11,729 children from 21 US-based websites. This study followed up with the participants from August 2018 to January 2021. Participants were asked to complete a survey about tobacco use, including e-cigarettes, cigarettes, cigars, smokeless tobacco, hookah, pipes, and nicotine replacement products.


Dai and colleagues utilized a comprehensive combination of cognitive assessment measures, including the National Institutes of Health Toolbox Cognitive Battery, morphometric analysis, and structural MRI, to evaluate differences between users and non-users. In terms of race and ethnicity, 2.1% of the sample were Asian; 20.3% were Hispanic/Latino; 14.9% were non-Hispanic Black; and 52.1% were non-Hispanic White. Just over a quarter (27.3%) of the sample had parents who were college graduates, and 13.7% had parents with an annual income less than $25,000.


During a two-year follow-up period, the scores of first-time tobacco users in oral recognition (b=-2.1; SE, 0.5; P<.001), picture sequencing memory (b=-3.0; SE, 0.7; P<.001), and crystallized cognitive composite scores (b=-2.7; SE, 0.8; P=.005) remained lower than non-users. In SMRI analysis, former smokers exhibited significantly decreased measurements in the entire brain, including the total cortical surface area in the first wave (b=-5014.8 mm3; SE, 7043.9; P=.002), total cortical volume in the first wave (b=-174,621.0 mm3; SE, 5857.7; P=.003) and follow-up (b=-21,790.8 mm3; SE, 7043.9; P=.002), and total intracranial volume in the first wave (b=-38,442.8 mm3; SE, 12,057.7; P=.009).


In a related editorial, Dr. Laviolette from the University of Western Ontario wrote, "The findings reported by Dai and colleagues raise many important questions for future clinical and preclinical investigations. It is important to determine the extent to which these pathophysiological findings extend beyond the window of brain maturation prior to adolescence. Furthermore, it is crucial to identify the specific molecular mechanisms and biomarkers underlying these persistent tobacco-induced pathophysiological effects.


He added that the description of potential mechanisms could facilitate similar identification of intervention and reversal strategies for "neurological and psychiatric phenotypes caused by nicotine exposure in children, adolescents, and even prenatal exposure." Additionally, advances in genomic and transcriptomic analysis could better understand the potential genetic factors that could make individuals more susceptible to nicotine products during critical periods of brain development, as well as factors that could increase the risk of serious neurological and cognitive outcomes after exposure to nicotine during the developmental window for some individuals.


Statement: 1. This article's content is based on the compilation of third-party information and is intended solely for industry exchanges and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is for industry exchange and research purposes only. 3. Due to limited compilation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy. 4. Regarding any domestic, Hong Kong, Macao, Taiwan, or international statements or positions, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and author. Please contact us for removal if there are any infringements.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
COP11 to Convene in Geneva in November; South Korea May Leverage Global Consensus to Advance Tobacco-Control Reforms
The 11th Conference of the Parties (COP11) to the WHO Framework Convention on Tobacco Control (FCTC) will be held in Geneva, Switzerland, from November 7 to 22, 2025. The meeting is expected to focus on the disclosure of tobacco constituents, environmental impacts, and industry responsibility. South Korea plans to implement the Tobacco Harmfulness Management Act in November and is preparing to send a delegation to COP11 to help align domestic regulations with international standards.
Sep.05 by 2FIRSTS.ai
Arkansas to Ban Non-FDA Approved Vapes Starting September 1
Arkansas to Ban Non-FDA Approved Vapes Starting September 1
Arkansas’ new law, Act 590, will restrict the sale of certain vape products across the state. The law requires retailers to sell only products that are approved or under review by the U.S. Food and Drug Administration (FDA), and bans packaging or designs that appeal to minors. Violations could result in product seizures, fines, or even license revocation.
Aug.27 by 2FIRSTS.ai
Ministry of Finance of Malaysia: Total tobacco tax revenue reaches $3.3 billion since 2021, with e-cigarettes accounting for only 2%
Ministry of Finance of Malaysia: Total tobacco tax revenue reaches $3.3 billion since 2021, with e-cigarettes accounting for only 2%
Malaysia's tobacco tax revenue surges, contributing over RM15.3 billion (approximately $3.3 billion) from 2021 to 2025, with e-cigarette tax revenue hitting a record high, reflecting clear consumption trends.
Aug.26 by 2FIRSTS.ai
Vaping and the Environment: A Call for Responsible Harm Reduction
Vaping and the Environment: A Call for Responsible Harm Reduction
Tobacco harm reduction expert Lindsey Stroud examines the environmental impact of vape waste, citing global research from Circular Vape Recycle. She highlights the risks of plastics, lithium batteries, and nicotine pollution, and stresses that education, recycling programs, and manufacturer responsibility are key alternatives to bans, enabling environmental protection and harm reduction to progress together.
Aug.15 by 2FIRSTS.ai
Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending
Wisconsin Set to Ban Non-FDA Approved Vapes Starting September, Court Ruling Pending
Wisconsin is planning to prohibit the sale of all vape products that have not been approved by the U.S. Food and Drug Administration (FDA) starting September 1. At present, WISCOFAST, a non-profit trade association formed by vape shop owners, has filed a lawsuit against the state government in an attempt to block the law from taking effect. The court is expected to rule later this week on whether the ban will be enforced.
Aug.27 by 2FIRSTS.ai
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
Research Abstract | Flavored E-Cigarettes Disrupt Placental Development and Pregnancy Outcomes Regardless of Nicotine Content
A new study shows that flavored e-cigarettes, even without nicotine, can interfere with embryo implantation and placental development, increasing the risks of miscarriage and fetal growth restriction, underscoring their potential threat to pregnancy safety.
Sep.01 by 2FIRSTS.ai